Axicabtagene-ciloleucel/DexamethasoneCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2025卷 / 1期

关键词：

D O I：

10.1007/s40278-024-66476-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：64 / 64

相关论文

共 50 条

[21] TisagenlecleucelCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1946 (1) : 515 - 515
[22] Axicabtagene-ciloleucelCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and neurotoxicity: 3 case reports
Reactions Weekly, 2020, 1823 (1) : 84 - 84
[23] AntineoplasticsLack of efficacy, cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2022, 1934 (1) : 48 - 48
[24] Axicabtagene-ciloleucel/brexucabtagene-autoleucel/tisagenlecleucelSinus bradycardia secondary to immune effector cell‐ associated neurotoxicity syndrome and cytokine release syndrome: 4 case reports
Reactions Weekly, 2022, 1924 (1) : 97 - 97
[25] TisagenlecleucelCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2023, 1944 (1) : 526 - 526
[26] PembrolizumabCytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2024, 2028 (1) : 430 - 430
[27] Axicabtagene-ciloleucel/tocilizumabCytokine release syndrome and neurotoxicity: 3 case reports
Reactions Weekly, 2021, 1854 (1) : 72 - 72
[28] Ciltacabtagene-autoleucelCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy
Reactions Weekly, 2024, 2000 (1) : 111 - 111
[29] Multiple drugsCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1896 (1) : 299 - 299
[30] Multiple drugsCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1889 (1) : 212 - 212

← 1 2 3 4 5 →